Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

Delayed Quote. Delayed  - 10/28 07:37:20 pm
22.24 USD   +3.49%
10/27 BOSTON SCIENTIF : To Participate In Stifel 2016 Healthcare Conferenc..
10/26 BOSTON SCIENTIF : sales growth exceeds expectations as profits rise
10/26 BOSTON SCIENTIF : profits rise 13 percent, beating forecasts
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Boston Scientific : Launches Resolution 360 Clip

share with twitter share with LinkedIn share with facebook
share via e-mail
10/27/2016 | 08:00pm CEST

By a News Reporter-Staff News Editor at Gastroenterology Week -- Boston Scientific Corporation (NYSE: BSX) announced the launch of the Resolution 360™ Clip, a novel technology designed to improve hemostatic clipping by providing physicians controlled rotation designed for more accurate clip placement. Boston Scientific will introduce the clip at the annual United European Gastroenterology Week (UEGW) in Vienna, Austria, and at the American College of Gastroenterology annual meeting in Las Vegas, Nevada (see also Boston Scientific Corporation).

Hemostatic clipping is used in a number of endoscopy procedures of the upper and lower gastrointestinal (GI) tract to stop and help prevent bleeding associated with conditions including peptic ulcers, polyps removed during a colonoscopy and diverticulosis of the colon. There are more than 240,000 incidences of GI bleeding in the U.S. each year(1) and worldwide a 10 percent mortality rate is associated with upper and lower GI bleeds.(2 )A retrospective study demonstrated that prophylactic clipping can reduce the risk of bleeding from a 9.8 percent to 1.7 percent leading to a reduction in adverse events associated with GI bleeding.(3)

"The Resolution 360 Clip gives me the unique advantage of controlling the movement and placement of the clip while also maneuvering the scope during the clipping procedure," said David L. Carr-Locke, MD, FRCP, FASGE, chief, Division of Digestive Diseases, Mount Sinai Beth Israel Medical Center, New York, NY. "The ability to have complete control can help improve the accuracy of clip placement and the speed of the procedure particularly in complex cases."

The device is constructed using a multi-wire braided catheter that is designed to enable the healthcare professional to rotate the device in small, controlled movements in both clockwise and counterclockwise directions, enabling the clip to be maneuvered to the target area and more accurately placed at the site of a GI bleed or a potential GI bleed. Physicians at the two conferences will have the opportunity to use the Resolution 360 Clip in a simulator to experience the device first-hand.

"We are always striving to improve our technology so that physicians have the tools they need to diagnose and treat gastrointestinal disease more easily and effectively," said Art Butcher, senior vice president and president, endoscopy. "Building on the legacy Resolution Clip and its clinically proven technology, the expanded portfolio now offers physicians more hemostatic clipping options to consider in different clinical situations and patient anatomies."

Keywords for this news article include: Technology, Gastroenterology, Risk and Prevention, Boston Scientific Corporation.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2016, NewsRx LLC

(c) 2016 NewsRx LLC, source Health Newsletters

share with twitter share with LinkedIn share with facebook
share via e-mail
10/27 BOSTON SCIENTIFIC : Launches Resolution 360 Clip
10/27 BOSTON SCIENTIFIC : To Participate In Stifel 2016 Healthcare Conference
10/26 BOSTON SCIENTIFIC : sales growth exceeds expectations as profits rise
10/26 BOSTON SCIENTIFIC : profits rise 13 percent, beating forecasts
10/26 BOSTON SCIENTIFIC : meets 3Q profit forecasts
10/26 BOSTON SCIENTIFIC CORP : Results of Operations and Financial Condition, Financia..
10/26 BOSTON SCIENTIFIC : Announces Results For Third Quarter 2016
10/25 BOSTON SCIENTIFIC : To Participate In 25th Annual Credit Suisse Healthcare Confe..
10/24 BOSTON SCIENTIFIC : Announces Scheduled Presentations at Transcatheter Cardiovas..
10/20 BOSTON SCIENTIFIC : Trademark Application for "AGENT" Filed
More news
Sector news : Advanced Medical Equipment & Technology - NEC
10/27DJTHERMO FISHER SCIENTIFIC : Correction to Thermo Fisher Scientific's Earnings
10/27DJNXP Semiconductors Profit Drops Sharply
10/24DJPHILIPS : Profit Lifted by Health-Care Business
10/11 Wall Street stocks slide, dollar hits 8-month high
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
10/26 Boston Scientific (BSX) Q3 2016 Results - Earnings Call Transcript
10/26 BIOTECH FORUM DAILY DIGEST : Earnings Season Begins, Election Still Looms Large
10/26 Boston Scientific revenues up 12%; non-GAAP EPS up 13% in Q3; shares up 3% pr..
10/26 Boston Scientific EPS in-line, beats on revenue
10/25 Notable earnings before Wednesday?s open
Financials ($)
Sales 2016 8 349 M
EBIT 2016 1 925 M
Net income 2016 742 M
Debt 2016 4 462 M
Yield 2016 -
P/E ratio 2016 41,46
P/E ratio 2017 22,40
EV / Sales 2016 4,04x
EV / Sales 2017 3,56x
Capitalization 29 242 M
More Financials
Duration : Period :
Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | 4-Traders
Full-screen chart
Technical analysis trends BOSTON SCIENTIFIC...
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 27,7 $
Spread / Average Target 29%
Consensus details
EPS Revisions
More Estimates Revisions
Michael F. Mahoney Chairman, President & Chief Executive Officer
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Keith D. Dawkins Global Chief Medical Officer & Executive VP
Nelda J. Connors Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PHILIPS16.55%28 395
ILLUMINA, INC.-27.43%20 420
More Results